| Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms JS Mandelblatt, KA Cronin, S Bailey, DA Berry, HJ De Koning, G Draisma, ... Annals of internal medicine 151 (10), 738-747, 2009 | 847* | 2009 |
| Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis HD Nelson, B Zakher, A Cantor, R Fu, J Griffin, ES O'Meara, DSM Buist, ... Annals of internal medicine 156 (9), 635-648, 2012 | 680 | 2012 |
| Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012 SK Plevritis, D Munoz, AW Kurian, NK Stout, O Alagoz, AM Near, SJ Lee, ... Jama 319 (2), 154-164, 2018 | 317 | 2018 |
| Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies JS Mandelblatt, NK Stout, CB Schechter, JJ Van Den Broek, DL Miglioretti, ... Annals of internal medicine 164 (4), 215-225, 2016 | 316 | 2016 |
| Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts BL Sprague, NK Stout, C Schechter, NT Van Ravesteyn, M Cevik, ... Annals of internal medicine 162 (3), 157-166, 2015 | 240 | 2015 |
| Interpreting overdiagnosis estimates in population-based mammography screening R de Gelder, EAM Heijnsdijk, NT van Ravesteyn, J Fracheboud, ... Epidemiologic reviews 33 (1), 111-121, 2011 | 238 | 2011 |
| Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review EEL Jansen, N Zielonke, A Gini, A Anttila, N Segnan, Z Vokó, U Ivanuš, ... European journal of cancer 127, 207-223, 2020 | 216 | 2020 |
| Radiation-induced breast cancer incidence and mortality from digital mammography screening: a modeling study DL Miglioretti, J Lange, JJ Van Den Broek, CI Lee, NT Van Ravesteyn, ... Annals of internal medicine 164 (4), 205-214, 2016 | 205 | 2016 |
| Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality D Munoz, AM Near, NT Van Ravesteyn, SJ Lee, CB Schechter, O Alagoz, ... Journal of the National Cancer Institute 106 (11), dju289, 2014 | 184 | 2014 |
| Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits I Lansdorp-Vogelaar, R Gulati, AB Mariotto, CB Schechter, ... Annals of internal medicine 161 (2), 104-112, 2014 | 169 | 2014 |
| Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography NK Stout, SJ Lee, CB Schechter, K Kerlikowske, O Alagoz, D Berry, ... Journal of the National Cancer Institute 106 (6), dju092, 2014 | 167 | 2014 |
| Impact of colorectal cancer screening on cancer-specific mortality in Europe: a systematic review A Gini, EEL Jansen, N Zielonke, RGS Meester, C Senore, A Anttila, ... European Journal of Cancer 127, 224-235, 2020 | 166 | 2020 |
| Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk NT Van Ravesteyn, DL Miglioretti, NK Stout, SJ Lee, CB Schechter, ... Annals of internal medicine 156 (9), 609-617, 2012 | 155 | 2012 |
| Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review N Zielonke, A Gini, EEL Jansen, A Anttila, N Segnan, A Ponti, P Veerus, ... European journal of cancer 127, 191-206, 2020 | 141 | 2020 |
| Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes A Trentham-Dietz, K Kerlikowske, NK Stout, DL Miglioretti, CB Schechter, ... Annals of internal medicine 165 (10), 700-712, 2016 | 127 | 2016 |
| The impact of the Covid-19 pandemic on breast cancer early detection and screening JD Figueroa, E Gray, N Pashayan, S Deandrea, A Karch, DB Vale, ... Preventive medicine 151, 106585, 2021 | 112 | 2021 |
| The potential of breast cancer screening in Europe N Zielonke, LM Kregting, EAM Heijnsdijk, P Veerus, S Heinävaara, ... International journal of cancer 148 (2), 406-418, 2021 | 91 | 2021 |
| Effects of cancer screening restart strategies after COVID-19 disruption LM Kregting, S Kaljouw, L de Jonge, EEL Jansen, EFP Peterse, ... British journal of cancer 124 (9), 1516-1523, 2021 | 84 | 2021 |
| Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States NT Van Ravesteyn, CB Schechter, AM Near, EAM Heijnsdijk, MA Stoto, ... Cancer epidemiology, biomarkers & prevention 20 (1), 112-122, 2011 | 83 | 2011 |
| Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis NT Van Ravesteyn, NK Stout, CB Schechter, EAM Heijnsdijk, O Alagoz, ... Journal of the National Cancer Institute 107 (7), djv103, 2015 | 73 | 2015 |
